Optimized and Validated Stability Indicating RP-HPLC Method for Estimation of Nadolol
暂无分享,去创建一个
[1] G. Spólnik,et al. Radiodegradation of nadolol in the solid state and identification of its radiolysis products by UHPLC–MS method , 2018, Chemical Papers.
[2] A. A. Salem,et al. Determination of Some β-Blockers and β2-Agonists in Plasma and Urine Using Liquid Chromatography-tandem Mass Spectrometry and Solid Phase Extraction. , 2017, Journal of chromatographic science.
[3] H. Jain,et al. Estimation of Nadolol in Bulk and Tablets by Area under Curve and First Order Derivative Spectrophotometry , 2016 .
[4] A. Rodrigues,et al. Separation of Nadolol Stereoisomers Using Chiralpak IA Chiral Stationary Phase. , 2016, Chirality.
[5] Sarfaraz Niazi,et al. Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.
[6] Bhupinder Singh,et al. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide. , 2014, Journal of pharmaceutical and biomedical analysis.
[7] Cecil R. Reynolds,et al. Physicians' Desk Reference , 2014 .
[8] Y. Agrawal,et al. Development of forced degradation and stability indicating studies of drugs—A review , 2013, Journal of pharmaceutical analysis.
[9] V. Merino,et al. Validation of Two High-Performance Liquid Chromatographic Methods for the Analysis of Nadolol and Propranolol Hydrochloride Following In Vitro Transdermal Diffusion Studies , 2011 .
[10] Maria Inês Rocha Miritello Santoro,et al. Quantitative Determination of Nadolol in Tablets by High‐Performance Liquid Chromatography and UV‐Derivative Spectrophotometry , 2008 .
[11] O. A. Adegoke,et al. A new spectrophotometric method for the determination of nadolol , 2006 .
[12] H. Saleh,et al. Colorimetric determination of β-blockers in pharmaceutical formulations , 2002 .
[13] Saranjit Singh,et al. Development of validated stability-indicating assay methods--critical review. , 2002, Journal of pharmaceutical and biomedical analysis.
[14] I. Blair,et al. Simultaneous determination of nadolol enantiomers in human plasma by high-performance liquid chromatography using fluorescence detection. , 1995, Biomedical chromatography : BMC.
[15] N. Srinivas,et al. High-performance liquid chromatographic assay for the quantitation of nadolol in human plasma using fluorescence detection. , 1995, Biomedical chromatography : BMC.
[16] E. G. Lovering,et al. Nadolol: high-pressure liquid chromatographic methods for assay, racemate composition and related compounds. , 1992, Journal of Pharmaceutical and Biomedical Analysis.
[17] K. Yoshida,et al. Determination of nadolol in serum by high-performance liquid chromatography with fluorimetric detection. , 1992, Journal of chromatography.
[18] J. Kirschbaum,et al. High-performance liquid chromatographic analysis of nadolol and bendroflumethiazide combination tablet formulations. , 1984, Journal of pharmaceutical sciences.
[19] R. B. Haynes,et al. Liquid-chromatographic determination of nadolol in plasma. , 1983, Clinical chemistry.
[20] J. Kirschbaum,et al. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs. , 1981, Journal of pharmaceutical sciences.
[21] E. Ivashkiv. Colorimetric determination of nadolol in tablets , 1978 .
[22] M. Malley,et al. Determination of serum nadolol levels by GLC--selected ion monitoring mass spectrometry: comparison with a spectrofluorometric method. , 1978, Journal of pharmaceutical sciences.
[23] E. Ivashkiv. Fluorometric determination of nadolol in human serum and urine. , 1977, Journal of pharmaceutical sciences.
[24] K. Rothschild. THE PHYSICIANS' DESK REFERENCE OF MEDICAL ECONOMICS , 1947 .
[25] Sean C. Sweetman. Comprar Martindale the complete reference 36th Ed | Sean Sweetman | 9780853698401 | Pharmaceutical Press , 2010 .
[26] H. Aboul‐Enein,et al. Conductimetric, Potentiometric and Visual Titrimetric Methods for Analysis of Nadolol , 1981 .